Effect of Rapamycin in Ovarian Aging
Study of Rapamycin in Delaying the Start of Menopause
Sponsor: Impetus
Enrolling: Female Patients Only
IRB Number: AAAU1074
U.S. Govt. ID: NCT05836025
Contact: Stephanie Morgan: 212-314-8837 / sm3415@cumc.columbia.edu
Additional Study Information: Researchers at Columbia are looking at new treatments to help delay the start of menopause. This is a randomized trial where some women will receive medication and some will receive a placebo. The study will last approximately 12 weeks, followed by monthly follow-ups for 6 months. Participants will be compensated $1300 for compensation.
Investigator
S. Zev Williams, MD, PhD
Do You Qualify?
Are you a woman between 35 and 45? Yes No
Do you have monthly periods? Yes No
Are you currently going through menopause? Yes No
Do you currently have liver or kidney disease, or any other serious medical condition? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Stephanie Morgan
sm3415@cumc.columbia.edu
212-314-8837
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE